Grifols | GRFS - Ingresos Por Ventas

Precio De Mercado
8.21
Cambio Diario
0.16 1.99%
Mensual
2.24%
Anual
21.45%
Q2 Expectativa
7.99




Ventas Cambio Fecha
Alaunos Therapeutics USD 2K 2K 2025-03
Arca Biopharma 0 0 2025-03
aTyr Pharma USD 110.08M 109.89M 2025-12
Bio Path 0 0 2025-03
Brainstorm Cell Therapeutics 0 0 2025-03
Capricor Therapeutics USD 11.13M 8.87M 2024-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Esperion Therapeutics USD 168.45M 81.14M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Grifols EUR 2.34B 33.3M 2026-03
Infinity Pharmaceuticals USD 583K 148K 2023-06
Minerva Neurosciences USD 0 0 2024-09
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
TherapeuticsMD USD 234K 79K 2024-06